Daito Pharmaceutical Co Ltd
TSE:4577
Daito Pharmaceutical Co Ltd
Interest Income Expense
Daito Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Daito Pharmaceutical Co Ltd
TSE:4577
|
Interest Income Expense
¥718m
|
CAGR 3-Years
24%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥172.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-28%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥47B
|
CAGR 3-Years
172%
|
CAGR 5-Years
53%
|
CAGR 10-Years
9%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥45.9B
|
CAGR 3-Years
33%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥1B
|
CAGR 3-Years
164%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
-¥10.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
Daito Pharmaceutical Co Ltd
Glance View
Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
See Also
What is Daito Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
718m
JPY
Based on the financial report for Nov 30, 2024, Daito Pharmaceutical Co Ltd's Interest Income Expense amounts to 718m JPY.
What is Daito Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
32%
The average annual Interest Income Expense growth rates for Daito Pharmaceutical Co Ltd have been 24% over the past three years , 32% over the past five years .
You don't have any saved screeners yet